Calcium regulation by skeletal muscle membranes of horses with recurrent exertional rhabdomyolysis

American Journal of Veterinary Research

Volumn 61, Issue 3, 2000, Pages 242-247

  Ward, Tara L ^a   Valberg, Stephanie J ^a   Gallant, Esther M ^a   Mickelson, James R ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EQUIDAE;

ADENOSINE TRIPHOSPHATASE (CALCIUM); CAFFEINE; CALCIUM; RYANODINE; RYANODINE RECEPTOR;

ANIMAL; ANIMAL DISEASE; ARTICLE; BIOPSY; CHEMISTRY; DOSE RESPONSE; EXERCISE; FEMALE; HORSE; HORSE DISEASE; MALE; PATHOPHYSIOLOGY; PHYSIOLOGY; RECURRENT DISEASE; RHABDOMYOLYSIS; SARCOPLASMIC RETICULUM; SCINTILLATION COUNTING; SKELETAL MUSCLE;

ANIMALS; BIOPSY; CAFFEINE; CALCIUM; CALCIUM-TRANSPORTING ATPASES; DOSE-RESPONSE RELATIONSHIP, DRUG; EXERTION; FEMALE; HORSE DISEASES; HORSES; MALE; MUSCLE, SKELETAL; RECURRENCE; RHABDOMYOLYSIS; RYANODINE; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; SARCOPLASMIC RETICULUM; SCINTILLATION COUNTING;

EID: 0034146311     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.2000.61.242     Document Type: Article

References (29)

1. Valberg SJ, Hodgson JR. Diseases of muscle. In, Smith BP, ed. Large animal internal medicine. St Louis, Mo: Mosby Year Book Inc, 1996;92-97.
2. MacLeay JM, Sorum SA, Valberg SJ, et al. Epidemiological factors influencing exertional rhabdomyolysis in Thoroughbred racehorses. Am J Vet Res 1999;60:1562-1566.
3. Beech J, Fletcher JE, Lizzo F, et al. Effect of phenytoin on the clinical signs and in vitro muscle twitch characteristics in horses with chronic intermittent rhabdomyolysis and myotonia. Am J Vet Res 1988;49:2130-2132.
4. Klein LA. A review of 50 cases of post-operative myopathy in the horse-intrinsic and management factors affecting risk, in Proceedings. Am Assoc Equine Pract 1978;24:89-94.
5. + regulation defects. Physiol Rev 1996;76:537-592.
6. Gronert GA. Malignant hyperthermia. In, Engel AC, Banker BQ, eds. Myology. New York: McGraw Hill Book Co, 1986;1763-1784.
7. Lentz LA, Valberg SJ, Balog EM, et al. Abnormal regulation of muscle contraction in horses with recurrent exertional rhabdomyolysis. Am J Vet Res 1999;60:992-999.
8. European Malignant Hyperpyrexia Group. A protocol for the investigation of malignant hyperpyrexia susceptibility. Br J Anaesth 1984;56:1267-1269.
9. Gallant EM, Gronert GA, Taylor SR. Cellular membrane potentials and contractile threshold in mammalian skeletal muscle susceptible to malignant hyperthermia. Neurosci Lett 1982;28:181-186.
10. Gallant EM, Lentz LR. Excitation-contraction coupling in pigs heterozygous for malignant hyperthermia. Am J Physiol 1992;262: C422-C426.
11. Lopez JR, Linares N, Cordovez G, et al. Elevated myoplasmic calcium in exercise-induced equine rhabdomyolysis. Eur J Physiol 1995;430:293-295.
12. Lopez JR. Free calcium concentration in skeletal muscle of malignant hyperthermia susceptible subjects. Effects of ryanodine. In, Ohnishi ST, Ohnishi TO, eds. Malignant hyperthermia. A genetic membrane disease. Boca Raton, Fla: CRC Press, 1994;134-150.
13. + release channels. Am J Med 1998;104:470-86.
14. MacLeay JM, Valberg SJ, Sorum S, et al. Heritable basis of recurrent exertional rhabdomyolysis in Thoroughbred racehorses. Am J Vet Res 1999;60:250-256.
15. Fujii J, Otsu K, Zorzato F, et al. Identification of a mutation in porcine ryanodine receptor associated with malignant hyperthermia. Sci Wash DC 1991;253:448-451.
16. + release channels and their regulation by endogenous effectors. Annu Rev Physiol 1994;56: 485-508.
17. Monnier N, Proaccio V, Stieglitz P, et al. Malignant-hyperthermia susceptibility is associated with a mutation of the α1-subunit of the human dihydropyridine-sensitive L-type voltage-dependent calcium-channel receptor in skeletal muscle. Am J Hum Genet 1997;60:1316-1325
18. Iles DE, Lehmann-Horn F, Scherer SW, et al. Localization of the gene encoding the α2/δ subunits of the L-type voltage-dependent calcium channel to chromosome 7q and analysis of the flanking markers in malignant hyperthermia susceptible families. Hum Mol Genet 1994;3:969-975.
19. +-adenosine triphosphatase in sarcoplasmic reticulum (Brody's Disease). Ann Neurol 1986;20:38-49.
20. +-ATPase, are associated with Brody's disease. Nature 1996;14:191-194.
21. Mickelson JR, Gallant EM, Litterer LA, et al. Abnormal sarcoplasmic reticulum ryanodine receptor in malignant hyperthermia. J Biol Chem 1988;263:9310-9315.
22. + release by direct and specific action at skeletal muscle ryanodine receptors. J Biol Chem 1997;272: 26965-26971.
23. Richter M, Schleithoff L, Deufel T, et al. Functional characterization of a distinct ryanodine receptor mutation in human malignant hyperthermia-susceptible muscle. J Biol Chem 1997;272:5256-5260.
24. Mickelson JR, Ervasti JM, Litterer LA, et al. Skeletal muscle junctional membrane protein content in pigs with different ryanodine receptor genotypes. Am J Physiol 1994;267:C282-C292.
25. Lowry OH, Rosebrough NJ, Farr AL, et al. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193: 265-275.
26. Brooks SPJ, Story KB. Bound and determined: a computer program for making buffers of defined ion concentrations. Anal Biochem 1992;201:119-126.
27. Beech J, Lindborg S, Fletcher JE, et al. Caffeine contractures, twitch characteristics and the threshold for calcium-induced calcium release in skeletal muscle from horses with chronic intermittent rhabdomyolysis. Res Vet Sci 1993;54:110-117.
28. Rios E, Brum G. Voltage sensor of excitation-contraction coupling in skeletal muscle. Physiol Rev 1991;71:849-906.
29. + release channel. Am J Physiol 1994;267:C1253-C1261.